Anemia and mortality in patients with nondialysis-dependent chronic kidney disease

A combination of safety concerns and labeling changes impacted use of erythropoiesis-stimulating agents (ESAs) in renal anemia. Data regarding contemporary utilization in pre-dialysis chronic kidney disease (C...

Source: BMC Nephrology - June 11, 2018 Category: Urology & Nephrology Authors: Heide A. Stirnadel-Farrant, Jiacong Luo, Lata Kler, Borut Cizman, Delyth Jones, Steven M. Brunelli and Alexander R. Cobitz Tags: Research article Source Type: research